Using intravenous iron to treat anemia after heart surgery in older patients
Official title: Intravenous Iron to Treat Postoperative Anemia in Older Cardiac Surgery Patients: a Randomized Controlled Trial'
Run by St. Antonius Hospital · NCT04913649 · Data updated 2026-11-12
This study is testing if giving intravenous iron can help older patients recover from anemia after heart surgery and improve their overall well-being.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 70 Years and up |
| Sex | All |
| Enrollment | 310 (estimated) |
| Sponsor | St. Antonius Hospital Academic / other |
| Locations | 2 sites (Breda and 1 other locations) |
| Status | Recruiting |
| Started | September 23, 2021 |
| Main results expected | November 2026 |
| Study ends | December 2026 |
| Registry record updated | April 27, 2026 |
| Trial ID | NCT04913649 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are elderly patients aged 70 and older who are undergoing elective cardiac surgery and have moderate postoperative iron deficiency anemia.
✕Probably not a fit
Patients with a history of iron overload, severe renal failure, or recent intravenous iron treatment may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effectiveness of intravenous iron treatment for older patients experiencing postoperative anemia following elective cardiac surgeries, such as aortic valve repair and coronary artery bypass grafting. The study will involve 310 patients aged 70 and above, who will be randomly assigned to receive either intravenous iron or a placebo. The primary outcome will be assessed using the World Health Organization Disability Assessment score 90 days after surgery, alongside secondary measures related to dyspnea and health-related quality of life. The trial is designed as a double-blind, placebo-controlled study conducted at two centers.
Why it matters
Potential benefit: If successful, this treatment could significantly improve recovery and quality of life for older cardiac surgery patients suffering from postoperative anemia.
How similar studies have gone: Other studies have shown promising results with intravenous iron treatment for anemia, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Mentally competent with age ≥ 70 years * Elective AVR or CABG surgery * Expected uncomplicated postoperative trajectory, defined as: * No inotropic agents or ventilation at time of final inclusion (POD 1) * Expected discharge to general ward at POD 1 * Moderate postoperative IDA, defined as: * Hb between 85 and 110 g/L and * Ferritin \<100 µg/L or * Iron saturation (TSAT) \< 20% Exclusion Criteria: * Medical history of iron overload/haemochromatosis * Medical history of liver cirrhosis or ALT/AST value in blood serum triple of normal value (female patients: ALT \>120, AST \>105 U/L. Male patients: ALT\>150, AST\>135 U/L) * Severe renal failure (eGFR\<15ml/min/1.73m2) * Recent treatment with IVI (\<12 weeks prior) * Serious or severe allergic reaction to IVI in medical history * Severe asthma or eczema in medical history (atopic constitution)
Where it's running
-
Amphia Hospital
Breda, Netherlands Recruiting -
St Antonius Hospital
Nieuwegein, Netherlands Recruiting
Study contacts
- Principal investigator: Peter Noordzij, MD, PhD — St. Antonius Hospital
- Study coordinator: Peter Noordzij, MD, PhD
- Email: p.noordzij@antoniusziekenhuis.nl
- Phone: 883203000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Iron treatment for children and young adults with Crohn’s disease and iron deficiency anemia
This study tests how different iron treatment approaches work for kids and young adults with Crohn’s disease and iron deficiency anemia.
-
Donor Breast Milk with Early Iron Supplementation in Very Preterm Infants
In very preterm babies who mainly receive donor breast milk, this study tests whether starting iron supplementation earlier (around when feeding reaches 80 ml/kg/day) can raise ferritin and hematocrit levels by days 14 and 28.
-
Preconception versus early-pregnancy iron screening and treatment
This trial tests whether screening and treating iron deficiency before conception is better than starting screening and iron treatment in early pregnancy for preventing iron deficiency anemia later in pregnancy.
-
Ferric derisomaltose injection in adults with iron deficiency anemia under fasting conditions
This study tests whether a ferric derisomaltose injection given to adults with iron deficiency anemia in a fasting state works similarly to a reference product and is safe to use.
-
FACE-APPS approach to improve iron in adolescent girls in marginalized communities
This study tests a blended program of face-to-face counseling and mobile app activities to see if it improves iron levels in adolescent girls with iron deficiency.
-
Acupoint TENS vs. Resistance Training for Iron Deficiency Anemia in Women
This trial tests whether acupoint transcutaneous electrical nerve stimulation (Acu-TENS) or resistance exercise, in addition to standard care, can raise hemoglobin levels in women with iron deficiency anemia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.